Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tizanidine extended-release driving performance crossover study
2015-003770-32Phase 2Completed
- Sponsor
- Sun Pharma Advanced Research Company
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tizanidine extended release in acute musculoskeletal pain (4 arms), sponsored by Sun Pharma Advanced Research Company. Primary endpoint: Standard deviation of lateral position. Started Jan 2016; status: completed.
02
Drugs
tizanidine extended release
03
Conditions
acute musculoskeletal pain
Beyond the preview
Go deeper on 2015-003770-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003770-32.